SecurityCNAB / United Cannabis Corp. (909747107)
IndustryCannabis and Medical Marijuana Dispensaries
Institutional Owners0
Common Shares Outstanding71,427,273 shares (as of 2018-06-30)

Institutional Stock Ownership and Shareholders

United Cannabis Corp. (OTC:CNAB) has 0 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include .
United Cannabis Corp. (OTC:CNAB) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Prev Value
Current Value
2018-08-14 13F-HR PANAGORA ASSET MANAGEMENT INC 211 0 -100.00 0 0
CNAB : United Cannabis Corp Analysis and Research Report

2017-11-25 - Asif

United Cannabis was originally formed on November 15, 2007 as a California corporation under the name MySkin, Inc. MySkin was engaged in the business of providing management services to a medical spa in Los Angeles, California which provided various advanced skin care services until March 31, 2014, when this business was sold to the former President of the Company. In early 2014 the company decided to exit the medical spa management business and change its focus to creating unique products which can be used to treat a wide range of diseases that can be used by patients globally. The company's products are subject to all existing marijuana laws in the United States. The company own intellectual property relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products. United Cannabis has entered into what the company believe are significant agreements with partners wh...

Related News Stories

United Cannabis Corporation Gives Guidance on Third Quarter Results

2018-10-09 accesswire
Company To Report $2 Million In Revenue For The Third Quarter, Forecasting $10 Million For the Year

United Cannabis Corporation Receives Conditional Approval From Jamaica's Cannabis Licensing Authority

2018-09-25 accesswire
Company Is Initiating Activities To Establish Infrastructure For The Cultivation, Processing, Transportation and Research Of Cannabis

United Cannabis Corporation Begins Clinical Trials On Its Prana P1 THC Activated Capsules For Chronic Pain

2018-08-01 accesswire
DENVER, CO / ACCESSWIRE / August 1, 2018 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals P1 Capsules for the treatment of chronic pain at Jamaica's University of the West Indies.

United Cannabis Corporation Gives Guidance on 2018 Results

2018-07-12 accesswire
Company to Report $2 Million in Revenue for the Second Quarter, Up 1400% Over 2017, Forecasting $10 Million for the Year (0-1)

United Cannabis Corporation Prana Bio Nutrient Patent Declared Effective In South Africa

2018-07-10 accesswire
DENVER, CO / ACCESSWIRE / July 10, 2018 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that the South African Patent Office has declared effective the Company's patent application based upon PCT/US2015/056635, and pursuant to the Patent Cooperation Treaty (PCT), for "Cannabis Extracts and Methods of Preparing and Using Same."

CUSIP: 909747107